+
データを開く
-
基本情報
| 登録情報 | データベース: PDB / ID: 5ait | ||||||
|---|---|---|---|---|---|---|---|
| タイトル | A complex of of RNF4-RING domain, UbeV2, Ubc13-Ub (isopeptide crosslink) | ||||||
要素 |
| ||||||
キーワード | LIGASE/SIGNALING PROTEIN / LIGASE-SIGNALING PROTEIN COMPLEX / COMPLEX | ||||||
| 機能・相同性 | 機能・相同性情報response to human chorionic gonadotropin / regulation of spindle assembly / regulation of kinetochore assembly / SUMO polymer binding / Antigen processing: Ubiquitination & Proteasome degradation / error-free postreplication DNA repair / UBC13-MMS2 complex / Translesion synthesis by REV1 / Recognition of DNA damage by PCNA-containing replication complex / Translesion Synthesis by POLH ...response to human chorionic gonadotropin / regulation of spindle assembly / regulation of kinetochore assembly / SUMO polymer binding / Antigen processing: Ubiquitination & Proteasome degradation / error-free postreplication DNA repair / UBC13-MMS2 complex / Translesion synthesis by REV1 / Recognition of DNA damage by PCNA-containing replication complex / Translesion Synthesis by POLH / Downregulation of ERBB4 signaling / Spry regulation of FGF signaling / Downregulation of ERBB2:ERBB3 signaling / NOD1/2 Signaling Pathway / APC/C:Cdc20 mediated degradation of Cyclin B / APC-Cdc20 mediated degradation of Nek2A / EGFR downregulation / TCF dependent signaling in response to WNT / NRIF signals cell death from the nucleus / p75NTR recruits signalling complexes / NF-kB is activated and signals survival / Activated NOTCH1 Transmits Signal to the Nucleus / Downregulation of TGF-beta receptor signaling / TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) / Downregulation of SMAD2/3:SMAD4 transcriptional activity / SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription / Senescence-Associated Secretory Phenotype (SASP) / Regulation of innate immune responses to cytosolic DNA / activated TAK1 mediates p38 MAPK activation / JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 / Regulation of FZD by ubiquitination / N-glycan trimming in the ER and Calnexin/Calreticulin cycle / Regulation of TNFR1 signaling / TNFR1-induced NF-kappa-B signaling pathway / Translesion synthesis by POLK / Translesion synthesis by POLI / Regulation of necroptotic cell death / HDR through Homologous Recombination (HRR) / Josephin domain DUBs / Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks / Processing of DNA double-strand break ends / Gap-filling DNA repair synthesis and ligation in GG-NER / Dual Incision in GG-NER / Fanconi Anemia Pathway / Regulation of TP53 Activity through Phosphorylation / Regulation of TP53 Degradation / Regulation of TP53 Activity through Methylation / Negative regulation of MET activity / PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 / Downregulation of ERBB2 signaling / E3 ubiquitin ligases ubiquitinate target proteins / Regulation of PTEN localization / ER Quality Control Compartment (ERQC) / Regulation of expression of SLITs and ROBOs / Interferon alpha/beta signaling / Endosomal Sorting Complex Required For Transport (ESCRT) / Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) / IKK complex recruitment mediated by RIP1 / IRAK2 mediated activation of TAK1 complex / TRAF6-mediated induction of TAK1 complex within TLR4 complex / Alpha-protein kinase 1 signaling pathway / RAS processing / Pexophagy / Negative regulation of FLT3 / IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation / Regulation of NF-kappa B signaling / Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 / Regulation of pyruvate metabolism / SCF-beta-TrCP mediated degradation of Emi1 / MAP3K8 (TPL2)-dependent MAPK1/3 activation / Ovarian tumor domain proteases / Cyclin D associated events in G1 / Regulation of BACH1 activity / Negative regulation of FGFR1 signaling / Negative regulation of FGFR2 signaling / Negative regulation of FGFR3 signaling / Negative regulation of FGFR4 signaling / Negative regulation of MAPK pathway / Formation of Incision Complex in GG-NER / Synthesis of active ubiquitin: roles of E1 and E2 enzymes / Inactivation of CSF3 (G-CSF) signaling / Termination of translesion DNA synthesis / Iron uptake and transport / Negative regulators of DDX58/IFIH1 signaling / Deactivation of the beta-catenin transactivating complex / Metalloprotease DUBs / Formation of TC-NER Pre-Incision Complex / Dual incision in TC-NER / Gap-filling DNA repair synthesis and ligation in TC-NER / Autodegradation of Cdh1 by Cdh1:APC/C / APC/C:Cdc20 mediated degradation of Securin / APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 / Cdc20:Phospho-APC/C mediated degradation of Cyclin A / Autodegradation of the E3 ubiquitin ligase COP1 / Asymmetric localization of PCP proteins / Degradation of AXIN / Degradation of DVL / Hedgehog ligand biogenesis / Hedgehog 'on' state / TNFR2 non-canonical NF-kB pathway 類似検索 - 分子機能 | ||||||
| 生物種 | ![]() HOMO SAPIENS (ヒト)![]() | ||||||
| 手法 | X線回折 / シンクロトロン / OTHER / 解像度: 3.4 Å | ||||||
データ登録者 | Branigan, E. / Naismith, J.H. | ||||||
引用 | ジャーナル: Nat.Struct.Mol.Biol. / 年: 2015タイトル: Structural Basis for the Ring Catalyzed Synthesis of K63 Linked Ubiquitin Chains 著者: Branigan, E. / Plechanovova, A. / Jaffray, E. / Naismith, J.H. / Hay, R.T. | ||||||
| 履歴 |
|
-
構造の表示
| 構造ビューア | 分子: Molmil Jmol/JSmol |
|---|
-
ダウンロードとリンク
-
ダウンロード
| PDBx/mmCIF形式 | 5ait.cif.gz | 179.3 KB | 表示 | PDBx/mmCIF形式 |
|---|---|---|---|---|
| PDB形式 | pdb5ait.ent.gz | 143.8 KB | 表示 | PDB形式 |
| PDBx/mmJSON形式 | 5ait.json.gz | ツリー表示 | PDBx/mmJSON形式 | |
| その他 | その他のダウンロード |
-検証レポート
| 文書・要旨 | 5ait_validation.pdf.gz | 475.9 KB | 表示 | wwPDB検証レポート |
|---|---|---|---|---|
| 文書・詳細版 | 5ait_full_validation.pdf.gz | 493.3 KB | 表示 | |
| XML形式データ | 5ait_validation.xml.gz | 32.4 KB | 表示 | |
| CIF形式データ | 5ait_validation.cif.gz | 44.1 KB | 表示 | |
| アーカイブディレクトリ | https://data.pdbj.org/pub/pdb/validation_reports/ai/5ait ftp://data.pdbj.org/pub/pdb/validation_reports/ai/5ait | HTTPS FTP |
-関連構造データ
-
リンク
-
集合体
| 登録構造単位 | ![]()
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 |
| ||||||||
| 単位格子 |
|
-
要素
| #1: タンパク質 | 分子量: 14758.155 Da / 分子数: 1 / 断片: RING DOMAIN, UNP RESIDUES 131-194,131-194 / 由来タイプ: 組換発現 詳細: THE RING DOMAIN IS DUPLICATED BUT AS A FUSED DIMER. THAT IS THE SEQUENCE OF THE RING DOMAIN FROM RNF4 (RESIDUES 131 TO 194) IS LINKED BY A SINGLE GLYCINE RESIDUE TO ANOTHER RING DOMAIN (RESIDUES 131 TO 194). 由来: (組換発現) ![]() ![]() 参照: UniProt: O88846, 合成酵素; C-N結合を形成; 酸-D-アミノ酸リガーゼ(ペプチド合成) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| #2: タンパク質 | 分子量: 17253.832 Da / 分子数: 2 / Mutation: YES / 由来タイプ: 組換発現 / 由来: (組換発現) HOMO SAPIENS (ヒト) / 発現宿主: ![]() #3: タンパク質 | 分子量: 8576.831 Da / 分子数: 2 / 断片: UNP RESIDUES 1-76 / 由来タイプ: 組換発現 / 由来: (組換発現) ![]() ![]() #4: タンパク質 | 分子量: 16508.861 Da / 分子数: 2 / 断片: UNP RESIDUES 1-145 / 由来タイプ: 組換発現 / 由来: (組換発現) HOMO SAPIENS (ヒト) / 発現宿主: ![]() #5: 化合物 | ChemComp-ZN / 配列の詳細 | THIS IS A HEAD TO TAIL FUSION OF TWO RING DOMAINS. THE GAMG AT THE N-TERMINUS IS A CLONING ARTEFACT ...THIS IS A HEAD TO TAIL FUSION OF TWO RING DOMAINS. THE GAMG AT THE N-TERMINUS IS A CLONING ARTEFACT THE ACTIVE SITE C87 HAS BEEN MUTATED TO K87 FOR ATTACHMENT | |
-実験情報
-実験
| 実験 | 手法: X線回折 / 使用した結晶の数: 1 |
|---|
-
試料調製
| 結晶 | マシュー密度: 2.87 Å3/Da / 溶媒含有率: 60 % 解説: DATA ARE 96 TO 3.5. THE DETECTOR WAS POSITION TO AVOID OVERLAP, DATA IN CORNERS 3.49 TO 3.4 ARE INCOMPLETE |
|---|
-データ収集
| 回折 | 平均測定温度: 100 K |
|---|---|
| 放射光源 | 由来: シンクロトロン / サイト: Diamond / ビームライン: I04 / 波長: 0.97949 |
| 検出器 | タイプ: ADSC CCD / 検出器: CCD / 日付: 2014年2月18日 |
| 放射 | プロトコル: SINGLE WAVELENGTH / 単色(M)・ラウエ(L): M / 散乱光タイプ: x-ray |
| 放射波長 | 波長: 0.97949 Å / 相対比: 1 |
| 反射 | 解像度: 3.4→67 Å / Num. obs: 14922 / % possible obs: 88.9 % / Observed criterion σ(I): 0 / 冗長度: 4.1 % / Rmerge(I) obs: 0.03 / Net I/σ(I): 25.7 |
| 反射 シェル | 解像度: 3.4→3.49 Å / 冗長度: 3.4 % / Rmerge(I) obs: 0.68 / Mean I/σ(I) obs: 1.9 / % possible all: 35 |
-
解析
| ソフトウェア |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 精密化 | 構造決定の手法: OTHER 開始モデル: NONE 解像度: 3.4→67.19 Å / Cor.coef. Fo:Fc: 0.952 / Cor.coef. Fo:Fc free: 0.915 / SU B: 37.502 / SU ML: 0.575 / 交差検証法: THROUGHOUT / ESU R Free: 0.711 / 立体化学のターゲット値: MAXIMUM LIKELIHOOD 詳細: HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. U VALUES REFINED INDIVIDUALLY. DISORDERED REGIONS WERE MODELED STEREOCHEMICALLY. THE ISOPEPTIDE LINKAGE WAS INCLUDED AS A RESTRAINT. THE PDB ...詳細: HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. U VALUES REFINED INDIVIDUALLY. DISORDERED REGIONS WERE MODELED STEREOCHEMICALLY. THE ISOPEPTIDE LINKAGE WAS INCLUDED AS A RESTRAINT. THE PDB FILE CANONOCAL PDB SHOWS THE BIOLOGICAL CONTEXT, HOWEVER DUE TO THE CHEMICAL CROSS LINK CANONICAL IS NOT FOUND IN THE CRYSTAL PER SE.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 溶媒の処理 | イオンプローブ半径: 0.8 Å / 減衰半径: 0.8 Å / VDWプローブ半径: 1.1 Å / 溶媒モデル: MASK | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 原子変位パラメータ | Biso mean: 139.669 Å2
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 精密化ステップ | サイクル: LAST / 解像度: 3.4→67.19 Å
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 拘束条件 |
|
ムービー
コントローラー
万見について





HOMO SAPIENS (ヒト)
X線回折
引用








PDBj










